BRCA1 and cancer: Although germline and somatic variants of BRCA1/2 have been described, variants in their genetic regions only account for a small proportion of cancer risk, and the majority is currently unknown, which remains a difficulty for genetic testing (Santana Dos Santos et al., 2018).